½ÃÀ庸°í¼­
»óǰÄÚµå
1262791

¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå ¸®Æ÷Æ®(2023³â)

Medical Bionic Implant/Artificial Organs Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ¼¼°è ½ÃÀåÀº 2022³â 210¾ï 3õ¸¸ ´Þ·¯¿¡¼­ 2023³â¿¡´Â 226¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, CAGR 7.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ ¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î COVID-19 ÆÒµ¥¹ÍÀÇ ¼¼°è °æÁ¦ ȸº¹ÀÇ °¡´É¼ºÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ÀÌ µÎ ±¹°¡ °£ÀÇ ÀüÀïÀº ¿©·¯ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý »ó½Â, °ø±Þ¸Á È¥¶õÀ¸·Î À̾îÁ³À¸¸ç, »óǰ°ú ¼­ºñ½º Àü¹Ý¿¡ ÀÎÇ÷¹À̼ÇÀ» ÀÏÀ¸ÄÑ ¼¼°è ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀåÀº 2027³â CAGR 6.9%·Î 296¾ï 1,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2022³â ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå¿¡¼­´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ÃÖ´ë Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå º¸°í¼­ÀÇ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, Áßµ¿ À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

±³Åë»ç°í¿Í »óÇØ Áõ°¡´Â ÇâÈÄ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±³Åë»ç°í³ª ºÎ»óÀ̶õ, °øµµ¿¡¼­ »ç°í¸¦ ´çÇØ, ÇÇÇØÀÚ¿¡°Ô ºÎ»óÀ» ÀÔÈ÷°Ô ÇÏ´Â »ç°ÇÀ» °¡¸®Åµ´Ï´Ù. Àΰø Àå±â ¹× Á¶Á÷ ´ëü´Â ÁÖ·Î Â÷·® »ç°í, Æø·Â ¹üÁË, ³ëµ¿ ÀçÇØ ¶Ç´Â ³­»êÀ» Æ÷ÇÔÇÑ ¿Ü»ó¼º »ç°ÇÀ¸·Î ÀÎÇÑ Àå±â ¼Õ»óÀ» º¹±¸Çϱâ À§ÇØ ¼öÇàµË´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 5¿ù ¹Ì±¹ Á¤ºÎ±â°üÀÎ National Highway Traffic Safety AdministrationÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â 2021³â¿¡ 4¸¸ 2,900¸í °¡±îÀÌ ÀÚµ¿Â÷ »ç°í·Î »ç¸ÁÇϰí ÀÖÀ¸¸ç, 2020³â¿¡´Â 3¸¸ 8,800¸í ±×¸®°í 10.5% Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯¹Ç·Î ±³Åë»ç°í¿Í ºÎ»ó Áõ°¡´Â ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀåÀÇ ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå Æ¯Â¡

Á¦3Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀåÀÇ µ¿Çâ°ú Àü·«

Á¦4Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • COVID-19ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå¿¡ ´ëÇÑ ¿ìÅ©¶óÀ̳ª-·¯½Ã¾Æ ÀüÀïÀÇ ¿µÇâ
  • ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå¿¡ ´ëÇÑ °íÀÎÇ÷¹À̼ÇÀÇ ¿µÇâ

Á¦5Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå ¿¹Ãø, 2022-2027F, 2032F
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®
  • ÀΰøÀå±â
  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, °íÁ¤ ¹æ¹ýº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀÓº£µðµå °¡´É
  • ¿ÜºÎ Âø¿ë
  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ±â¼úº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀüÀÚ
  • ±â°è
  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • º´¿ø
  • Áø·á¼Ò
  • ¿¬±¸±â°ü ¹× Çмú±â°ü
  • ±âŸ ¿ëµµ

Á¦7Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀåÀÇ Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°èÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, ±ÔÁ¦, ±ÔÁ¦ ±â°ü, ÁÖ¿ä ´Üü, °ú¼¼µÇ´Â ¼¼±Ý, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦9Àå Áß±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • Áß±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °³¿ä
  • Áß±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áß±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦10Àå ÀεµÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ÀεµÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀεµÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦11Àå ÀϺ»ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ÀϺ»ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ»ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • È£ÁÖ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • Àεµ³×½Ã¾ÆÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ³×½Ã¾ÆÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦14Àå Çѱ¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • Çѱ¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ¼­À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °³¿ä
  • ¼­À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ¿µ±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • µ¶ÀÏÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¶ÀÏÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½ºÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ÇÁ¶û½ºÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇÁ¶û½ºÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦19Àå µ¿À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • µ¿À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °³¿ä
  • µ¿À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾Æ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ·¯½Ã¾ÆÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¯½Ã¾ÆÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦21Àå ºÏ¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ºÏ¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °³¿ä
  • ºÏ¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦22Àå ¹Ì±¹ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ¹Ì±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °³¿ä
  • ¹Ì±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ì±¹ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦23Àå ³²¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ³²¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °³¿ä
  • ³²¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹ÌÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁú ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ºê¶óÁúÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁúÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • Áßµ¿ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °³¿ä
  • Áßµ¿ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå

  • ¾ÆÇÁ¸®Ä« ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/Àΰø Àå±â ½ÃÀå °æÀï ±¸µµ
  • ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Medtronic PLC
    • Boston Scientific Services Private Limited.
    • Abbott Laboratories Inc
    • Zimmer Biomet Holdings Inc.
    • Ekso Bionics Holdings Inc

Á¦28Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀåÀÇ ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦29Àå ÀÇ·á¿ë ¹ÙÀÌ¿À´Ð ÀÓÇöõÆ®/ÀΰøÀå±â ½ÃÀå Àü¸Á°ú ÀáÀ缺 ºÐ¼®

Á¦30Àå ºÎ·Ï

LSH 23.05.02

“Medical Bionic Implant/Artificial Organs Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical bionic implant/artificial organs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical bionic implant/artificial organs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The medical bionic implant/artificial organs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Bionic Implants; Artificial Organs
  • 2) By Method Of Fixation: Implantable; Externally Worn
  • 3) By Technology: Electronic; Mechanical
  • 4) By Application: Hospitals; Clinics; Research and Academic Institutes; Other Applications
  • Companies Mentioned: Medtronic PLC; Boston Scientific Services Private Limited.; Abbott Laboratories Inc; Zimmer Biomet Holdings Inc.; Ekso Bionics Holdings Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the medical bionic implant/artificial organs market are: Medtronic PLC, Boston Scientific Services Private Limited., Abbott Laboratories Inc., Zimmer Biomet Holdings Inc., Ekso Bionics Holdings Inc., Cochlear Limited, Cyberonics Inc., LIVANOVA PLC, NeuroPace Inc., Ossur India Private Limited, Vivani Medical Inc., St Jude Medical India Private Limited, LifeNet Health Inc., Ottobock SE & Co. KGaA, Edwards Lifesciences India PVT Ltd., SynCardia Systems LLC, Demant A/S, Berlin Heart GmbH, Conmed Devices Private Limited, and Wright Medical Group N.V.

The global medical bionic implant/artificial organs market is expected to grow from $21.03 billion in 2022 to $22.69 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical bionic implant/artificial organs market is expected to grow to $29.61 billion in 2027 at a CAGR of 6.9%.

The medical bionic implant artificial organs market consists of sales of pacemakers, ventricular assist device, artificial limb and fingers, exoskeletons, heart valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The medical bionic implant artificial organs refer to any machine, device, or other item employed to perform the functions of a damaged or absent organ or other portion of the human body. The medical bionic implant artificial organs are used to restore physical capability to a person with a disability, and a small, disparate set of implants that improve cardiac and neurological functions.

Asia-Pacific was the largest region in the medical bionic implant/artifical organs market in 2022. The regions covered in the medical bionic implant/artificial organs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of medical bionic implants/artificial organs are bionic implants and artificial organs. Bionic implants refer to the electronic or mechatronic components that improve or restore a person with a disability's physical capabilities. The method of fixation includes implantable and externally worn that use various technologies such as electronic and mechanical. The several applications include hospitals, clinics, research and academic institutes, and others.

The rise in road accidents and injuries is expected to propel the growth of the medical bionic implant/artificial organs market going forward. Road accidents and injuries refer to an incident on a public road that results in accidents and causing injuries to the victim. Artificial organ and tissue replacements are performed to repair organ damage that is primarily brought on by traumatic events including vehicle accidents, violent crimes, work-related injuries, or challenging births. For instance, in May 2022, according to National Highway Traffic Safety Administration, a US-based government agency data, in the US nearly 42.9 thousand people died in motor vehicle accidents in 2021, which was 38.8 thousand, a 10.5% more in 2020. Therefore, the rise in road accidents and injuries is driving the growth of the medical bionic implant/artificial organs market.

Strategic partnerships are a key trend gaining popularity in the medical bionic implant/artificial organs market. Many companies operating in the medical bionic implant /artificial organs market are undergoing partnerships to strengthen their position in the market. For instance, in September 2021, Bionic Vision Technologies (BVT), an Australia-based company operating in artificial organs partnered with Cirtec Medical, a US-based provider of outsourced medical device and components design, engineering, and manufacturing for an undisclosed amount. With this partnership, Cirtec would help BVT to develop and produce its next-generation bionic eye by obtaining a strategic stake in the Australian company. Further, in February 2022, HUMOTECH, a US-based research services company, engaged in artificial organs, partnered with the University of Michigan, a US-based, public research university for an undisclosed amount. This partnership aims to accelerate the development of bionic leg control software, which has the potential to give prosthetic users the strength and natural gait of a human leg. As part of this partnership, HUMOTECH develops updated versions of the open-source leg to accommodate prosthesis users and researchers.

In May 2022, LivaNova PLC, a UK-based medical device manufacturer acquired ALung Technologies, Inc for an undisclosed amount. This acquisition is expected to have a neutral impact on adjusted diluted earnings per share in 2022. This would continue to invest in the strategic portfolio initiatives, the phased launch of the next-generation heart-lung machine, Essenz, and expanded indications in advanced circulatory. ALung Technologies Inc is a US-based company that manufactures artificial organs.

The countries covered in the medical bionic implant/artificial organs market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The medical bionic implant/artificial organs market research report is one of a series of new reports from The Business Research Company that provides medical bionic implant/artificial organs market statistics, including medical bionic implant/artificial organs industry global market size, regional shares, competitors with a medical bionic implant/artificial organs market share, detailed medical bionic implant/artificial organs market segments, market trends and opportunities, and any further data you may need to thrive in the medical bionic implant/artificial organs industry. This medical bionic implant/artificial organs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Medical Bionic Implant/Artificial Organs Market Characteristics

3. Medical Bionic Implant/Artificial Organs Market Trends And Strategies

4. Medical Bionic Implant/Artificial Organs Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Medical Bionic Implant/Artificial Organs Market
  • 4.2. Ukraine-Russia War Impact On Medical Bionic Implant/Artificial Organs Market
  • 4.3. Impact Of High Inflation On Medical Bionic Implant/Artificial Organs Market

5. Medical Bionic Implant/Artificial Organs Market Size And Growth

  • 5.1. Global Medical Bionic Implant/Artificial Organs Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Medical Bionic Implant/Artificial Organs Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Medical Bionic Implant/Artificial Organs Market Segmentation

  • 6.1. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Bionic Implants
  • Artificial Organs
  • 6.2. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Method Of Fixation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Implantable
  • Externally Worn
  • 6.3. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Electronic
  • Mechanical
  • 6.4. Global Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Clinics
  • Research and Academic Institutes
  • Other Applications

7. Medical Bionic Implant/Artificial Organs Market Regional And Country Analysis

  • 7.1. Global Medical Bionic Implant/Artificial Organs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Medical Bionic Implant/Artificial Organs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Medical Bionic Implant/Artificial Organs Market

  • 8.1. Asia-Pacific Medical Bionic Implant/Artificial Organs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Medical Bionic Implant/Artificial Organs Market

  • 9.1. China Medical Bionic Implant/Artificial Organs Market Overview
  • 9.2. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Medical Bionic Implant/Artificial Organs Market

  • 10.1. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Medical Bionic Implant/Artificial Organs Market

  • 11.1. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Medical Bionic Implant/Artificial Organs Market

  • 12.1. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Medical Bionic Implant/Artificial Organs Market

  • 13.1. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Medical Bionic Implant/Artificial Organs Market

  • 14.1. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Medical Bionic Implant/Artificial Organs Market

  • 15.1. Western Europe Medical Bionic Implant/Artificial Organs Market Overview
  • 15.2. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Medical Bionic Implant/Artificial Organs Market

  • 16.1. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Medical Bionic Implant/Artificial Organs Market

  • 17.1. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Medical Bionic Implant/Artificial Organs Market

  • 18.4. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.5. France Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Medical Bionic Implant/Artificial Organs Market

  • 19.1. Eastern Europe Medical Bionic Implant/Artificial Organs Market Overview
  • 19.2. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Medical Bionic Implant/Artificial Organs Market

  • 20.1. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Medical Bionic Implant/Artificial Organs Market

  • 21.1. North America Medical Bionic Implant/Artificial Organs Market Overview
  • 21.2. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Medical Bionic Implant/Artificial Organs Market

  • 22.1. USA Medical Bionic Implant/Artificial Organs Market Overview
  • 22.2. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Medical Bionic Implant/Artificial Organs Market

  • 23.1. South America Medical Bionic Implant/Artificial Organs Market Overview
  • 23.2. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Medical Bionic Implant/Artificial Organs Market

  • 24.1. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Medical Bionic Implant/Artificial Organs Market

  • 25.1. Middle East Medical Bionic Implant/Artificial Organs Market Overview
  • 25.2. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Medical Bionic Implant/Artificial Organs Market

  • 26.1. Africa Medical Bionic Implant/Artificial Organs Market Overview
  • 26.2. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Medical Bionic Implant/Artificial Organs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Medical Bionic Implant/Artificial Organs Market Competitive Landscape And Company Profiles

  • 27.1. Medical Bionic Implant/Artificial Organs Market Competitive Landscape
  • 27.2. Medical Bionic Implant/Artificial Organs Market Company Profiles
    • 27.2.1. Medtronic PLC
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Boston Scientific Services Private Limited.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Abbott Laboratories Inc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Zimmer Biomet Holdings Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Ekso Bionics Holdings Inc
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Medical Bionic Implant/Artificial Organs Market

29. Medical Bionic Implant/Artificial Organs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦